Noninvasive pathway for stratifying fibrosis in suspected metabolic dysfunction and alcohol-associated liver disease (MetALD)
Luis Antonio Díaz(Pontificia Universidad Católica de Chile), Rohit Loomba(University of California San Diego), Claude B. Sirlin(University of California San Diego), Harris Siddiqi(University of California San Diego), Veeral Ajmera(University of California San Diego), Amy Johnson(Columbia University), David Martí‐Aguado(INCLIVA Health Research Institute), Monica A. Tincopa(University of California San Diego), Ricki Bettencourt(University of California San Diego), Ria Loomba(University of California San Diego), Federica Tavaglione(Università Campus Bio-Medico), Nikita Mittal(University of California San Diego), Lisa Richards(University of California San Diego), Egbert Madamba(University of California San Diego), Asma Khan-Riches(University of California San Diego), Maral Amangurbanova(University of California San Diego)
Cited by 14
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k